XML 29 R35.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Equity (Details) - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Equity [Abstract]    
Number of Options, Outstanding, Beginning balance 1,290,000 1,290,000
Number of Options Outstanding, Granted
Number of Options, Outstanding, Ending balance 1,290,000 1,290,000
Number of Options, Exercisable 1,165,000  
Weighted Average Exercise Price, Beginning balance $ 0.99 $ 0.99
Weighted Average Exercise Price, Granted
Weighted Average Exercise Price, Ending balance 0.99 $ 0.99
Weighted Average Exercise Price, Exercisable $ 0.99  
Weighted Average Remaining Contractual Term (Years), Outstanding, Beginning balance 6 years 8 months 26 days 7 years 8 months 26 days
Weighted Average Remaining Contractual Term (Years), Outstanding, Ending balance 5 years 8 months 26 days 6 years 8 months 26 days
Weighted Average Remaining Contractual Term (Years), Exercisable 5 years 7 months 10 days  
Aggregate Intrinsic Value, Beginning balance $ 126,500
Aggregate Intrinsic Value, Granted  
Aggregate Intrinsic Value, Ending balance
Aggregate Intrinsic Value, Exercisable  
Number of shares, Balance Non-vested at December 31, 2018 150,000  
Number of shares, Vested during the year (25,000)  
Number of shares, Balance Non-vested at June 30, 2019 125,000 150,000
Weighted Average Exercise Price, Balance Non-vested at December 31, 2018 $ 1.00  
Weighted Average Exercise Price, Vested during the year 1.00  
Weighted Average Exercise Price, Balance Non-vested at June 30, 2019 $ 1.00 $ 1.00
Weighted Average Remaining Contractual Term (Years), Balance Non-vested at December 31, 2018 6 years 8 months 26 days  
Weighted Average Remaining Contractual Term (Years), Balance Non-vested at June 30, 2019 5 years 8 months 26 days  
Aggregate Intrinsic Value, Balance Non-vested at December 31, 2018  
Aggregate Intrinsic Value, Balance Non-vested at June 30, 2019